Kerry Rosenthal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kerry Rosenthal has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Gabriella Frith
School of Sport and Physical Activity, Advanced Wellbeing Research Centre Sheffield Hallam University Sheffield UK
2 shared publications- Martin R. Lindley
School of Health Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia
2 shared publications Anna Myers
School of Sport and Physical Activity, Advanced Wellbeing Research Centre Sheffield Hallam University Sheffield UK
1 shared publication- Anna Myers
Sheffield Hallam University
1 shared publication Carol Keen
Sheffield Teaching Hospitals NHS Foundation Trust Royal Hallamshire Hospital Sheffield UK
1 shared publication- Carol Keen
Sheffield Teaching Hospitals, Sheffield, United Kingdom
1 shared publication
Latest Publications
- Open Access
- 21 April 2026
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 32 (3) , e70425
The Effect of Prehabilitation on Health Resource Use and 1‐Year Survival: An Observational Cohort Evaluation of the Active Together Service
Introduction: Research suggests that multi‐modal prehabilitation can improve quality of life and clinical outcomes. There is, however, limited evidence on the effect of prehabilitation on hospital resource use. Methods: This is a non‐randomised observational cohort evaluation. The intervention group were patients receiving multi‐modal prehabilitation (Active Together) before surgery for colorectal, lung or upper gastrointestinal cancer between January 2022 and March 2024. Patients who declined to participate in Active Together and historical patient data (2017–2021) were used as comparator groups. Outcome measures were length of hospital stay, length of critical care stay, total number of days spent in hospital as a readmission within 90 days following surgery, and one‐year survival rate. Results: Three hundred and five patients completed prehabilitation, 96 patients declined to join the service, and 869 patients were included in the historical dataset. Active Together colorectal patients spent less time in critical care than historical colorectal patients (0.9 vs 1.2 days, p = 0.011). Whereas Active Together lung patients spent longer in critical care than historical lung patients (2.5 vs 1.7 days, p < 0.001). One‐year survival rate was greater in Active Together patients compared to the declined group (95% vs 85%, p = 0.013) but did not differ significantly from the historical group (95% vs 92%, p = 0.140). The probability of prehabilitation being more cost‐effective than not receiving prehabilitation was 58%, 60%, and 59% for colorectal, lung and upper gastrointestinal patients, respectively. Conclusion: The impact of prehabilitation on healthcare resource use was mixed with promising evidence of a positive effect of prehabilitation and rehabilitation on overall survival. There were notable differences between tumour groups in these outcomes which warrants further investigation. Future research is needed to build on these findings by including a larger sample size, a wider range of tumour groups, and a longer follow up period.
- 21 April 2026
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 32 (3) , e70425
Open AccessThe Effect of Prehabilitation on Health Resource Use and 1‐Year Survival: An Observational Cohort Evaluation of the Active Together Service
Introduction: Research suggests that multi‐modal prehabilitation can improve quality of life and clinical outcomes. There is, however, limited evidence on the effect of prehabilitation on hospital resource use. Methods: This is a non‐randomised observational cohort evaluation. The intervention group were patients receiving multi‐modal prehabilitation (Active Together) before surgery for colorectal, lung or upper gastrointestinal cancer between January 2022 and March 2024. Patients who declined to participate in Active Together and historical patient data (2017–2021) were used as comparator groups. Outcome measures were length of hospital stay, length of critical care stay, total number of days spent in hospital as a readmission within 90 days following surgery, and one‐year survival rate. Results: Three hundred and five patients completed prehabilitation, 96 patients declined to join the service, and 869 patients were included in the historical dataset. Active Together colorectal patients spent less time in critical care than historical colorectal patients (0.9 vs 1.2 days, p = 0.011). Whereas Active Together lung patients spent longer in critical care than historical lung patients (2.5 vs 1.7 days, p < 0.001). One‐year survival rate was greater in Active Together patients compared to the declined group (95% vs 85%, p = 0.013) but did not differ significantly from the historical group (95% vs 92%, p = 0.140). The probability of prehabilitation being more cost‐effective than not receiving prehabilitation was 58%, 60%, and 59% for colorectal, lung and upper gastrointestinal patients, respectively. Conclusion: The impact of prehabilitation on healthcare resource use was mixed with promising evidence of a positive effect of prehabilitation and rehabilitation on overall survival. There were notable differences between tumour groups in these outcomes which warrants further investigation. Future research is needed to build on these findings by including a larger sample size, a wider range of tumour groups, and a longer follow up period.
- Open Access
The effect of prehabilitation on health resource use and one-year survival: The Active Together Service
Introduction: Research suggests that multi-modal prehabilitation can improve quality of life and clinical outcomes. There is limited evidence, however, on the effect of prehabilitation on hospital resource use. Materials and Methods: Patients receiving surgery for colorectal, lung or upper gastrointestinal cancer between January 2022 and March 2024, were referred to a multi-modal prehabilitation service (Active Together). Patients who declined to participate in Active Together and historical patient data (2017-2021) were used as comparator groups. Outcome measures were length of hospital stay, length of critical care stay, the total number of days spent in hospital as a readmission in the 90 days following surgery, and one-year survival rate. Results: 305 patients completed prehabilitation, 96 patients declined to join the service, and 869 patients were included in the historical dataset. Active Together colorectal patients spent less time in critical care than historical colorectal patients (0.9 vs 1.2 days, p = 0.011). Whereas Active Together lung patients spent longer in critical care than historical lung patients (2.5 vs 1.7 days, p < 0.001). One-year survival rate was greater in Active Together patients compared to the declined group (95% vs 85%, p= 0.013), and not significantly different from the historical group (95% vs 92%, p= 0.14). The probability of the prehabilitation being cost saving was 58%, 60%, and 59% for colorectal, lung and upper gastrointestinal patients, respectively. Conclusion: Prehabilitation has a limited effect on healthcare resource use and may improve one-year survival. Further research with large sample sizes is required to confirm small differences.
Open AccessThe effect of prehabilitation on health resource use and one-year survival: The Active Together Service
Introduction: Research suggests that multi-modal prehabilitation can improve quality of life and clinical outcomes. There is limited evidence, however, on the effect of prehabilitation on hospital resource use. Materials and Methods: Patients receiving surgery for colorectal, lung or upper gastrointestinal cancer between January 2022 and March 2024, were referred to a multi-modal prehabilitation service (Active Together). Patients who declined to participate in Active Together and historical patient data (2017-2021) were used as comparator groups. Outcome measures were length of hospital stay, length of critical care stay, the total number of days spent in hospital as a readmission in the 90 days following surgery, and one-year survival rate. Results: 305 patients completed prehabilitation, 96 patients declined to join the service, and 869 patients were included in the historical dataset. Active Together colorectal patients spent less time in critical care than historical colorectal patients (0.9 vs 1.2 days, p = 0.011). Whereas Active Together lung patients spent longer in critical care than historical lung patients (2.5 vs 1.7 days, p < 0.001). One-year survival rate was greater in Active Together patients compared to the declined group (95% vs 85%, p= 0.013), and not significantly different from the historical group (95% vs 92%, p= 0.14). The probability of the prehabilitation being cost saving was 58%, 60%, and 59% for colorectal, lung and upper gastrointestinal patients, respectively. Conclusion: Prehabilitation has a limited effect on healthcare resource use and may improve one-year survival. Further research with large sample sizes is required to confirm small differences.
- Open Access
- 15 November 2021
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 13 (45) , 5441-5449
Volatile atmospheric pressure chemical ionisation mass spectrometry headspace analysis ofE. coliandS. aureus
Identifying the characteristics of bacterial species can improve treatment outcomes and mass spectrometry methods have been shown to be capable of identifying biomarkers of bacterial species. This study is the first to use volatile atmospheric pressure chemical ionisation mass spectrometry to directly and non-invasively analyse the headspace of E. coli and S. aureus bacterial cultures, enabling major biological classification at species level (Gram negative/positive respectively). Four different protocols were used to collect data, three utilising discrete 5 min samples taken between 2 and 96 h after inoculation and one method employing 24 h continuous sampling. Characteristic marker ions were found for both E. coli and S. aureus. A model to distinguish between sample types was able to correctly identify the bacteria samples after sufficient growth (24–48 h), with similar results obtained across different sampling methods. This demonstrates that this is a robust method to analyse and classify bacterial cultures accurately and within a relevant time frame, offering a promising technique for both clinical and research applications.
- 15 November 2021
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 13 (45) , 5441-5449
Open AccessVolatile atmospheric pressure chemical ionisation mass spectrometry headspace analysis ofE. coliandS. aureus
Identifying the characteristics of bacterial species can improve treatment outcomes and mass spectrometry methods have been shown to be capable of identifying biomarkers of bacterial species. This study is the first to use volatile atmospheric pressure chemical ionisation mass spectrometry to directly and non-invasively analyse the headspace of E. coli and S. aureus bacterial cultures, enabling major biological classification at species level (Gram negative/positive respectively). Four different protocols were used to collect data, three utilising discrete 5 min samples taken between 2 and 96 h after inoculation and one method employing 24 h continuous sampling. Characteristic marker ions were found for both E. coli and S. aureus. A model to distinguish between sample types was able to correctly identify the bacteria samples after sufficient growth (24–48 h), with similar results obtained across different sampling methods. This demonstrates that this is a robust method to analyse and classify bacterial cultures accurately and within a relevant time frame, offering a promising technique for both clinical and research applications.
- 30 September 2019
- Published by IOP Publishing in Journal of Breath Research
- Vol. 13 (4) , 046013
Breath selection methods for compact mass spectrometry breath analysis
Compact mass spectrometry (CMS) is a versatile and transportable analytical instrument that has the potential to be used in clinical settings to quickly and non-invasively detect a wide range of relevant conditions from breath samples. The purpose of this study is to optimise data preprocessing protocols by three proposed methods of breath sampling, using the CMS. It also lays out a general framework for which data processing methods can be evaluated. Methods. This paper considers data from three previous studies, each using a different breath sampling method. These include a peppermint washout study using continuous breath sampling with a purified air source, an exercise study using continuous breath sampling with an ambient air source, and a single breath sampling study with an ambient air source. For each dataset, different breath selection (data preprocessing) methods were compared and benchmarked according to predictive performance on a validation set and quantitative reliability of m / z bin intensity measurements. Results. For both continuous methods, the best breath selection method improved the predictive model compared to no preselection, as measured by the 95% CI range for Youden’s index, from 0.68–0.86 to 0.86–0.97 for the exercise study and 0.69–0.82 to 1.00–1.00 for the peppermint study. The reliability of intensity measurements for both datasets (as measured by median relative standard deviation (RSD)), was improved slightly by the best selection method compared to no preselection, from 18% to 14% for the exercise study and 7%–5% for the peppermint study. For the single breath samples, all the models resulted in perfect prediction, with a 95% CI range for Youden’s index of 1.00–1.00. The reliability of the proposed method was 38%. Conclusion. The method of selecting exhaled breath from CMS data can affect the reliability of the measurement and the ability to distinguish between breath samples taken under different conditions. The application of appropriate data processing methods can improve the quality of the data and results obtained from CMS. The methods presented will enable untargeted analysis of breath VOCs using CMS to be performed.
- 30 September 2019
- Published by IOP Publishing in Journal of Breath Research
- Vol. 13 (4) , 046013
Breath selection methods for compact mass spectrometry breath analysis
Compact mass spectrometry (CMS) is a versatile and transportable analytical instrument that has the potential to be used in clinical settings to quickly and non-invasively detect a wide range of relevant conditions from breath samples. The purpose of this study is to optimise data preprocessing protocols by three proposed methods of breath sampling, using the CMS. It also lays out a general framework for which data processing methods can be evaluated. Methods. This paper considers data from three previous studies, each using a different breath sampling method. These include a peppermint washout study using continuous breath sampling with a purified air source, an exercise study using continuous breath sampling with an ambient air source, and a single breath sampling study with an ambient air source. For each dataset, different breath selection (data preprocessing) methods were compared and benchmarked according to predictive performance on a validation set and quantitative reliability of m / z bin intensity measurements. Results. For both continuous methods, the best breath selection method improved the predictive model compared to no preselection, as measured by the 95% CI range for Youden’s index, from 0.68–0.86 to 0.86–0.97 for the exercise study and 0.69–0.82 to 1.00–1.00 for the peppermint study. The reliability of intensity measurements for both datasets (as measured by median relative standard deviation (RSD)), was improved slightly by the best selection method compared to no preselection, from 18% to 14% for the exercise study and 7%–5% for the peppermint study. For the single breath samples, all the models resulted in perfect prediction, with a 95% CI range for Youden’s index of 1.00–1.00. The reliability of the proposed method was 38%. Conclusion. The method of selecting exhaled breath from CMS data can affect the reliability of the measurement and the ability to distinguish between breath samples taken under different conditions. The application of appropriate data processing methods can improve the quality of the data and results obtained from CMS. The methods presented will enable untargeted analysis of breath VOCs using CMS to be performed.